What is the recommended diagnosis and treatment for onychomycosis (fungal infection of the toenails)?

Treatment of Toenail Fungal Infection (Onychomycosis)

For toenail onychomycosis, oral terbinafine 250 mg daily for 12-16 weeks is the first-line treatment, offering superior cure rates (55% complete cure, 46% long-term mycological cure) compared to all alternatives. 1

Confirm the Diagnosis First

Before starting any antifungal therapy, you must obtain mycological confirmation through microscopy and/or fungal culture, as approximately half of nail dystrophies are not fungal 2, 3. Clinical appearance alone is insufficient—subungual hyperkeratosis, yellow-orange discoloration, and onycholysis are suggestive but require laboratory confirmation.

Treatment Algorithm

For Dermatophyte Infections (Most Common)

First-line: Oral Terbinafine

• Dose: 250 mg daily for 12-16 weeks for toenails 1
• Efficacy: 55% complete cure at 72 weeks, with only 23% mycological relapse at 5 years 1
• Advantages: Minimal drug interactions (only CYP2D6), lower hepatotoxicity than alternatives, cost-effective 1
• Monitoring: Baseline liver function tests and complete blood count if history of heavy alcohol use, hepatitis, or hematological abnormalities 1
• Key warning: Permanent taste disturbance is rare but possible—counsel patients 1

Second-line: Oral Itraconazole (if terbinafine contraindicated)

• Dose: Either 200 mg daily for 12 weeks continuously OR pulse therapy 400 mg daily for 1 week per month for 3 pulses 1
• Efficacy: 26% complete cure with pulse therapy, 53% relapse rate at 5 years 1
• Disadvantages: More drug interactions via cytochrome P450, lower cure rates than terbinafine 1

Third-line: Oral Fluconazole (off-label, when others not tolerated)

• Dose: 450 mg weekly for at least 6 months for toenails 1
• Efficacy: 47-62% mycological cure but only 28-36% clinical cure 1
• Advantage: Once-weekly dosing may improve compliance 1
• Disadvantage: 58% discontinuation rate at higher doses due to adverse effects 1

For Candida Infections

Itraconazole is first-line for Candida onychomycosis due to shorter treatment duration and superior efficacy over terbinafine 1:

• Dose: 200 mg daily OR pulse therapy 400 mg daily for 1 week per month, minimum 4 weeks for fingernails, 12 weeks for toenails 1
• Alternative: Fluconazole 50 mg daily or 300 mg weekly 1
• Terbinafine requires 48 weeks for adequate Candida cure rates (70-85%), making it impractical 1

Topical Therapy Limitations

Topical antifungals as monotherapy are only appropriate for:

• Early distal lateral subungual onychomycosis with <80% nail involvement
• No lunula involvement
• When systemic therapy is contraindicated 1

Amorolfine 5% lacquer (if topical chosen):

• Apply once weekly for 6-12 months after filing diseased nail 1
• ~50% efficacy for distal disease, but mycological cure rates 30% lower than clinical improvement 1

Efinaconazole 10% solution (newer topical):

• Daily application for 48 weeks
• 50% mycological cure, 15% complete cure 1

Critical Management Points

Re-evaluate at 3-6 months after treatment initiation—give additional treatment if disease persists 1. The nail takes 12-18 months to fully grow out, so clinical improvement lags behind mycological cure.

Avoid these pitfalls:

• Never use griseofulvin as first-line (only 30-40% cure rate, requires 12-18 months) unless other drugs unavailable 1
• Don't use systemic terbinafine in active/chronic liver disease 1
• Don't start treatment without mycological confirmation—you'll treat non-fungal dystrophies unnecessarily 2, 3

Combination therapy (oral + topical) increases cure rates and should be considered for moderate-to-severe disease 4, 5.